The "Veterinary X-ray Market by Technology, Type, Mobility, Animal, Application, End User- Forecast to 2023" report has been added to ResearchAndMarkets.com' s offering. The global veterinary X-ray market is projected to reach USD 872 million by 2023 from USD 640 million in 2018, at a CAGR of 6.4% from 2018 to 2023.. Digital X- ray Systems to Witne
Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country's reddest states, has an idea to fix Obamacare call in President Trump. Yet Democrats romped to victory in the House and limited their Senate losses in a very unfavorable map, leaving a divided government and a chance for the White House to step in and find
Industry Report Titled "Urology Devices Market Research Report- Forecast to 2023" is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally. The Global Urology Devices Market is driven by rapid development in the medical devices, launch of new devices, and rising prevalence
Aggressive Lymphoma Results from Prospective Clinical Trials: New Agents Date and Time: Sunday, December 2, 2018; 12:15 p.m. PT Location: Marriott Marquis San Diego Marina, Pacific Ballroom 20 Presenter: John Radford, MD, FRCP, Manchester Academic Health Centre, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.
Agency: " Food and Drug Administration, HHS." Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the no
Agency: " Food and Drug Administration, HHS." SUMMARY: The Food and Drug Administration is announcing that a proposed collection of information has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995.. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food an
Aldeyra Therapeutics, Inc., a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced financial results for the third quarter ended September 30, 2018. Aldeyra plans to initiate a Phase 3 clinical trial in 2019, following discussions with regulatory.
NATIONAL HARBOR, Maryland, Nov. 13 The American Medical Association issued the following news release:. The American Medical Association, the premier national physician organization in the country, voted to adopt new policies on emerging health care topics during the voting session of its Interim Meeting. The AMA's House of Delegates is the polic
"Fact-based market research, penetrating industry insights and validated forecasts to help you make better decisions for a stronger future" Research Report on Ambulatory Services Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2016 To 2024 14 November 2018, The global Ambulatory Services Market is projecte
-American Physician Partners, LLC, a leader in emergency medicine and hospital medicine management services, is pleased to announce the acquisition of Progressive Medical Associates, PLLC based in Mesa, Ariz.. PMAs team of 37 physicians and 21 advanced practice clinicians care for approximately 150,000 emergency department patients annually at Bann
The American Society of Clinical Oncology issued the following news release:. "There is a significant shortage of palliative care providers, which will only worsen in the future as our population ages," said lead study author Mihir M. Kamdar, MD, Associate Director of the Division of Palliative Care and an interventional pain physician at Massachu
SAN DIEGO- Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that the first patient has been dosed in the Company's Phase 2 clinical program to evaluate the efficacy and safety of APX001 in the treatment of infections caused by Candida. 'Initiating our Phase 2 program for APX001...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that the first patient has been dosed in the Company`s Phase 2 clinical program to evaluate the efficacy and safety of APX001 in the treatment of infections caused by Candida. "Initiating our Phase 2 program for APX001 represents a
LONDON, GREATER LONDON, UK, November 14, 2018/ EINPresswire.com/ In North America, which accounts for over 30% of the global market, sales of drugs to treat or prevent infectious diseases are falling at 0.1% year on year, as Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 from The Business Research Company shows. Sales in
Bone cement is a material used for the fixation of joint implants to the bone. Chemical bone cement is Plexiglas, which is a polymer-based material comprising poly-methyl-methacrylate (PMMA) or co-polymers. Infection during orthopedic sur...
Aravive, Inc., a clinical-stage biopharmaceutical company, today announced detailed results of its first-in-human Phase 1 clinical trial of AVB-S6-500 in healthy volunteers. As previously announced, the trial met the safety and tolerability endpoints for the trial and demonstrated clinical proof-of-mechanism for AVB-S6-500 in neutralizing GAS6, a k
Attenua, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, today announced that the first patient has been treated in a Phase 2 clinical trial in chronic cough with bradanicline, its lead compound. "Within just six months of our initial Series A funding, Attenua has successfully filed an Inves
Augmented reality (AR) and virtual reality (VR) is the new way patients are diagnosed and treated. Remote surgery, hands on training, virtual medical learning, etc. are common applications of these two technologies in healthcare sector. Augmented r...
Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system disorders, today announced the completion of patient enrollment in the ASCEND study, a Phase 2 randomized, controlled trial of AXS-05 in major depressive disorder. ASCEND is evaluating the effect of AXS-05 as compa
Baxter International Inc., a leading global medical products company, is presenting four health economics and outcomes research analyses this week at the International Society for Pharmacoeconomics and Outcomes Research Europe 2018 meeting. Malnutrition occurs in roughly 40 to 60 percent of cancer patients worldwide1, 2 and is a frequent complicati
The Global Coalition for Adaptive Research and Bayer announced today that Bayer s regorafenib will be the first drug to enter GBM AGILE. GBM AGILE is a revolutionary patient-centered adaptive platform trial that will evaluate multiple therapies for patients with newly diagnosed and recurrent glioblastoma the deadliest form of brain canc
CAMBRIDGE, England& BOSTON Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide product platform, today announced that it has been recognized at the 2018 World ADC Awards, held during the World ADC Conference in San Diego, Calif., as Best New Drug Developer. Earlier this
Valley Cottage, NY 11/13/2018 Biochemicals control market has witnessed significant rise over the decades owing to technological advancement in healthcare industries. According to a recent study conducted by University of Wisconsin Carbone Cancer Center in Madison, USA, 35% of prostate cancer survivors are susceptible to biochemical relapse w
Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders, today reported financial results for the quarter ended September 30, 2018, and provided a review of recent accomplishments and...
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of...